Nectar Lifesciences informs about standalone financial results

23 Aug 2016 Evaluate

Nectar Lifesciences has informed about Standalone Financial Results, Limited Review for the period ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

39.11 1.76 (4.71%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.